Hodgkin’s lymphoma caused by EBV infection is one of the common reasons for the occurrence of lesions. Whether the corresponding tumor is curable or not is mainly judged by the clinical staging, and the clinical cure rate is high for the tumors of stage Ⅰ and Ⅱ through standardized treatment, and the clinical cure rate for the tumors of stage Ⅲ and Ⅳ is obviously reduced.
EBV infection-associated Hodgkin’s lymphoma is a malignant tumor occurring in lymph nodes and lymphatic tissues, which is mainly treated by chemotherapy (nitrogen mustard, vincristine, etc.) and radiotherapy, and the clinical evaluation of the cure rate is mainly based on the standard of 5-year survival rate, and the 5-year survival rate of Stage Ⅰ, Ⅱ can be more than 90%, while the annual survival rate of Stage Ⅲ, Ⅳ is less than 60%.
Early-stage lesions are relatively well cured. From the clinical point of view, it is necessary to achieve early detection, early diagnosis and early treatment to try to improve the cure rate and prolong the survival time.